Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 6/20 | 0.40 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.40 |
| ▸ | P4HTM | Q9NXG6 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.38 |
| ▸ | NPC1 | O15118 | 2/20 | 0.38 |
| ▸ | RAB9A | P51151 | 2/20 | 0.38 |
| ▸ | PKM | P14618 | 2/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | CES2 | O00748 | 1/20 | 0.37 |
| ▸ | CES1 | P23141 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.37 |
| ▸ | THRB | P10828 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5449917 | 0.97 | L3MBTL1 (0.40) | L3MBTL1LMNANAPRTP4HTMSMN1; SMN2 | |
| SCHEMBL811550 | 0.76 | KMT2A (0.49) | L3MBTL1LMNAKMT2AALDH1A1THRB | |
| SCHEMBL29120007 | 0.74 | L3MBTL1 (0.50) | L3MBTL1LMNANAPRTP4HTMSMN1; SMN2 | |
| SCHEMBL29120006 | 0.73 | CES2 (0.53) | L3MBTL1LMNANAPRTP4HTMSMN1; SMN2 | |
| SCHEMBL14609300 | 0.72 | ALDH1A1 (0.53) | L3MBTL1LMNANAPRTP4HTMSMN1; SMN2 | |
| SCHEMBL31633615 | 0.71 | CES2 (0.64) | L3MBTL1LMNANAPRTP4HTMNPSR1 | |
| SCHEMBL1228223 | 0.71 | CES2 (0.64) | L3MBTL1LMNANAPRTP4HTMNPSR1 | |
| SCHEMBL6078786 | 0.70 | CES2 (0.50) | L3MBTL1LMNANAPRTP4HTMSMN1; SMN2 | |
| SCHEMBL27454868 | 0.70 | KMT2A (0.61) | L3MBTL1LMNANAPRTP4HTMSMN1; SMN2 | |
| SCHEMBL27757257 | 0.70 | NPC1 (0.51) | L3MBTL1LMNANAPRTP4HTMSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130267483-A1 | Hydroxy Acid Complexes for Skin Antiaging, Acne, and Skin Whitening | BIODERM RESEARCH (US) | 2013-10-10 | — | — | US | disclosed |
| US-20120189569-A1 | Hydroxy Acid Complexes for Skin Renovation and Clarity | BIODERM RESEARCH (US) | 2012-07-26 | — | — | US | disclosed |
| US-20090209642-A1 | Hydroxy Acid Complexes for Antiaging and Skin Renovation | BIODERM RESEARCH (US) | 2009-08-20 | — | — | US | disclosed |
| US-7547454-B2 | Hydroxy acid complexes for antiaging and skin renovation | GUPTA SHYAM K | 2009-06-16 | — | — | US | disclosed |
| US-20070092461-A1 | Novel Hydroxy Acid Complexes for Antiaging and Skin Renovation | BIODERM RESEARCH (US) | 2007-04-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120189569-A1 | Hydroxy Acid Complexes for Skin Renovation and Clarity | CUTA, TYR, RBP4 | L3MBTL1 3628/4885LMNA 3463/4885NAPRT 2597/4885 |
| US-20090209642-A1 | Hydroxy Acid Complexes for Antiaging and Skin Renovation | CUTA, SLC30A6, SLC30A7 | L3MBTL1 2810/4885LMNA 3195/4885NAPRT 2821/4885 |
| US-20130267483-A1 | Hydroxy Acid Complexes for Skin Antiaging, Acne, and Skin Whitening | CUTA, TYR, SLC30A6 | L3MBTL1 2887/4885LMNA 2392/4885NAPRT 2991/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.